Genetic variation in the CYP1A1 gene is related to circulating PCB118 levels in a population-based sample

Environmental Research

Volumn 133, Issue , 2014, Pages 135-140

  Lind, Lars ^a   Penell, Johanna ^a   Syvänen, Anne Christine ^a   Axelsson, Tomas ^a   Ingelsson, Erik ^a,b   Morris, Andrew P ^b   Lindgren, Cecilia ^b   Salihovic, Samira ^c   van Bavel, Bert ^c   Lind, P Monica ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ÖREBRO UNIVERSITY   (Sweden)

Author keywords

CYP; Epidemiology; Gene; Metabolism; PCB; SNP

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; POLYCHLORINATED BIPHENYL; POLYCHLORINATED BIPHENYL 118; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGING POPULATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC VARIATION; HEALTH MONITORING; HEALTH SURVEY; PCB; PUBLIC HEALTH;

AGED; ARTICLE; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

CYP; EPIDEMIOLOGY; GENE; METABOLISM; PCB; SNP;

AGED; ARYL HYDROCARBON HYDROXYLASES; CROSS-SECTIONAL STUDIES; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP1A2; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; POLYCHLORINATED BIPHENYLS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84902206366     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.05.017     Document Type: Article

References (39)

1. Amin N., Byrne E., Johnson J., Chenevix-Trench G., Walter S., Nolte I.M., kConFab I., Vink J.M., Rawal R., Mangino M., Teumer A., Keers J.C., Verwoert G., Baumeister S., Biffar R., Petersmann A., Dahmen N., Doering A., Isaacs A., Broer L., Wray N.R., Montgomery G.W., Levy D., Psaty B.M., Gudnason V., Chakravarti A., Sulem P., Gudbjartsson D.F., Kiemeney L.A., Thorsteinsdottir U., Stefansson K., van Rooij F.J., Aulchenko Y.S., Hottenga J.J., Rivadeneira F.R., Hofman A., Uitterlinden A.G., Hammond C.J., Shin S.Y., Ikram A., Witteman J.C., Janssens A.C., Snieder H., Tiemeier H., Wolfenbuttel B.H., Oostra B.A., Heath A.C., Wichmann E., Spector T.D., Grabe H.J., Boomsma D.I., Martin N.G., van Duijn C.M. Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol. Psychiatry 2012, 17:1116-1129.
2. Cornelis M.C., Monda K.L., Yu K., Paynter N., Azzato E.M., Bennett S.N., Berndt S.I., Boerwinkle E., Chanock S., Chatterjee N., Couper D., Curhan G., Heiss G., Hu F.B., Hunter D.J., Jacobs K., Jensen M.K., Kraft P., Landi M.T., Nettleton J.A., Purdue M.P., Rajaraman P., Rimm E.B., Rose L.M., Rothman N., Silverman D., Stolzenberg-Solomon R., Subar A., Yeager M., Chasman D.I., van Dam R.M., Caporaso N.E. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet. 2011, 7:e1002033.
3. Edwards N.C., Hing Z.A., Perry A., Blaisdell A., Kopelman D.B., Fathke R., Plum W., Newell J., Allen C.E., Geetha S., Shapiro A., Okunji C., Kosti I., Shomron N., Grigoryan V., Przytycka T.M., Sauna Z.E., Salari R., Mandel-Gutfreund Y., Komar A.A., Kimchi-Sarfaty C. Characterization of coding synonymous and non-synonymous variants in ADAMTS13 using ex vivo and in silico approaches. PLoS One 2012, 7:e38864.
4. Fang J., Wang S., Wang H., Zhang S., Su S., Song Z., Deng Y., Qian J., Gu J., Liu B., Cao J., Wang Z. The Cytochrome P4501A1 gene polymorphisms and idiopathic male infertility risk: a meta-analysis. Gene 2014, 535:93-96.
5. Ghisari M., Long M., Bonefeld-Jorgensen E.C. Genetic polymorphisms in CYP1A1, CYP1B1 and COMT genes in Greenlandic Inuit and Europeans. Int. J. Circumpolar Health 2013, 72:21113.
6. Hakkola J., Pasanen M., Pelkonen O., Hukkanen J., Evisalmi S., Anttila S., Rane A., Mantyla M., Purkunen R., Saarikoski S., Tooming M., Raunio H. Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 1997, 18:391-397.
7. Hennig B., Meerarani P., Slim R., Toborek M., Daugherty A., Silverstone A.E., Robertson L.W. Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol. Appl. Pharmacol. 2002, 181:174-183.
8. Hestermann E.V., Stegeman J.J., Hahn M.E. Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. Toxicol. Appl. Pharmacol. 2000, 168:160-172.
9. International Consortium for Blood Pressure Genome-Wide Association S., Ehret G.B., Munroe P.B., Rice K.M., Bochud M., Johnson A.D., Chasman D.I., Smith A.V., Tobin M.D., Verwoert G.C., Hwang S.J., Pihur V., Vollenweider P., O'Reilly P.F., Amin N., Bragg-Gresham J.L., Teumer A., Glazer N.L., Launer L., Zhao J.H., Aulchenko Y., Heath S., Sober S., Parsa A., Luan J., Arora P., Dehghan A., Zhang F., Lucas G., Hicks A.A., Jackson A.U., Peden J.F., Tanaka T., Wild S.H., Rudan I., Igl W., Milaneschi Y., Parker A.N., Fava C., Chambers J.C., Fox E.R., Kumari M., Go M.J., van der Harst P., Kao W.H., Sjogren M., Vinay D.G., Alexander M., Tabara Y., Shaw-Hawkins S., Whincup P.H., Liu Y., Shi G., Kuusisto J., Tayo B., Seielstad M., Sim X., Nguyen K.D., Lehtimaki T., Matullo G., Wu Y., Gaunt T.R., Onland-Moret N.C., Cooper M.N., Platou C.G., Org E., Hardy R., Dahgam S., Palmen J., Vitart V., Braund P.S., Kuznetsova T., Uiterwaal C.S., Adeyemo A., Palmas W., Campbell H., Ludwig B., Tomaszewski M., Tzoulaki I., Palmer N.D., consortium C.A., Consortium C.K., KidneyGen C., EchoGen C., consortium C.-H., Aspelund T., Garcia M., Chang Y.P., O'Connell J.R., Steinle N.I., Grobbee D.E., Arking D.E., Kardia S.L., Morrison A.C., Hernandez D., Najjar S., McArdle W.L., Hadley D., Brown M.J., Connell J.M., Hingorani A.D., Day I.N., Lawlor D.A., Beilby J.P., Lawrence R.W., Clarke R., Hopewell J.C., Ongen H., Dreisbach A.W., Li Y., Young J.H., Bis J.C., Kahonen M., Viikari J., Adair L.S., Lee N.R., Chen M.H., Olden M., Pattaro C., Bolton J.A., Kottgen A., Bergmann S., Mooser V., Chaturvedi N., Frayling T.M., Islam M., Jafar T.H., Erdmann J., Kulkarni S.R., Bornstein S.R., Grassler J., Groop L., Voight B.F., Kettunen J., Howard P., Taylor A., Guarrera S., Ricceri F., Emilsson V., Plump A., Barroso I., Khaw K.T., Weder A.B., Hunt S.C., Sun Y.V., Bergman R.N., Collins F.S., Bonnycastle L.L., Scott L.J., Stringham H.M., Peltonen L., Perola M., Vartiainen E., Brand S.M., Staessen J.A., Wang T.J., Burton P.R., Soler Artigas M., Dong Y., Snieder H., Wang X., Zhu H., Lohman K.K., Rudock M.E., Heckbert S.R., Smith N.L., Wiggins K.L., Doumatey A., Shriner D., Veldre G., Viigimaa M., Kinra S., Prabhakaran D., Tripathy V., Langefeld C.D., Rosengren A., Thelle D.S., Corsi A.M., Singleton A., Forrester T., Hilton G., McKenzie C.A., Salako T., Iwai N., Kita Y., Ogihara T., Ohkubo T., Okamura T., Ueshima H., Umemura S., Eyheramendy S., Meitinger T., Wichmann H.E., Cho Y.S., Kim H.L., Lee J.Y., Scott J., Sehmi J.S., Zhang W., Hedblad B., Nilsson P., Smith G.D., Wong A., Narisu N., Stancakova A., Raffel L.J., Yao J., Kathiresan S., O'Donnell C.J., Schwartz S.M., Ikram M.A., Longstreth W.T., Mosley T.H., Seshadri S., Shrine N.R., Wain L.V., Morken M.A., Swift A.J., Laitinen J., Prokopenko I., Zitting P., Cooper J.A., Humphries S.E., Danesh J., Rasheed A., Goel A., Hamsten A., Watkins H., Bakker S.J., van Gilst W.H., Janipalli C.S., Mani K.R., Yajnik C.S., Hofman A., Mattace-Raso F.U., Oostra B.A., Demirkan A., Isaacs A., Rivadeneira F., Lakatta E.G., Orru M., Scuteri A., Ala-Korpela M., Kangas A.J., Lyytikainen L.P., Soininen P., Tukiainen T., Wurtz P., Ong R.T., Dorr M., Kroemer H.K., Volker U., Volzke H., Galan P., Hercberg S., Lathrop M., Zelenika D., Deloukas P., Mangino M., Spector T.D., Zhai G., Meschia J.F., Nalls M.A., Sharma P., Terzic J., Kumar M.V., Denniff M., Zukowska-Szczechowska E., Wagenknecht L.E., Fowkes F.G., Charchar F.J., Schwarz P.E., Hayward C., Guo X., Rotimi C., Bots M.L., Brand E., Samani N.J., Polasek O., Talmud P.J., Nyberg F., Kuh D., Laan M., Hveem K., Palmer L.J., van der Schouw Y.T., Casas J.P., Mohlke K.L., Vineis P., Raitakari O., Ganesh S.K., Wong T.Y., Tai E.S., Cooper R.S., Laakso M., Rao D.C., Harris T.B., Morris R.W., Dominiczak A.F., Kivimaki M., Marmot M.G., Miki T., Saleheen D., Chandak G.R., Coresh J., Navis G., Salomaa V., Han B.G., Zhu X., Kooner J.S., Melander O., Ridker P.M., Bandinelli S., Gyllensten U.B., Wright A.F., Wilson J.F., Ferrucci L., Farrall M., Tuomilehto J., Pramstaller P.P., Elosua R., Soranzo N., Sijbrands E.J., Altshuler D., Loos R.J., Shuldiner A.R., Gieger C., Meneton P., Uitterlinden A.G., Wareham N.J., Gudnason V., Rotter J.I., Rettig R., Uda M., Strachan D.P., Witteman J.C., Hartikainen A.L., Beckmann J.S., Boerwinkle E., Vasan R.S., Boehnke M., Larson M.G., Jarvelin M.R., Psaty B.M., Abecasis G.R., Chakravarti A., Elliott P., van Duijn C.M., Newton-Cheh C., Levy D., Caulfield M.J., Johnson T. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011, 478:103-109.
10. Josse A.R., Da Costa L.A., Campos H., El-Sohemy A. Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption. Am. J. Clin. Nutr. 2012, 96:665-671.
11. Kang J.H., Park H., Chang Y.S., Choi J.W. Distribution of organochlorine pesticides (OCPs) and polychlorinated biphenyls (PCBs) in human serum from urban areas in Korea. Chemosphere 2008, 73:1625-1631.
12. Knobeloch L., Turyk M., Imm P., Schrank C., Anderson H. Temporal changes in PCB and DDE levels among a cohort of frequent and infrequent consumers of Great Lakes sportfish. Environ. Res. 2009, 109:66-72.
13. Kumar P., Henikoff S., Ng P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 2009, 4:1073-1081.
14. Laden F., Ishibe N., Hankinson S.E., Wolff M.S., Gertig D.M., Hunter D.J., Kelsey K.T. Polychlorinated biphenyls, cytochrome P450 1A1, and breast cancer risk in the Nurses' Health Study. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1560-1565.
15. Lampa E., Lind L., Hermansson A.B., Salihovic S., van Bavel B., Lind P.M. An investigation of the co-variation in circulating levels of a large number of environmental contaminants. J. Expo. Sci. Environ. Epidemiol. 2012, 22:476-482.
16. Lind L., Fors N., Hall J., Marttala K., Stenborg A. A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Arterioscler. Thromb. Vasc. Biol. 2005, 25:2368-2375.
17. McGraw J., Waller D. Cytochrome P450 variations in different ethnic populations. Expert Opin. Drug Metab. Toxicol. 2012, 8:371-382.
18. Nebert D.W., Dalton T.P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat. Rev. Cancer 2006, 6:947-960.
19. Nebert D.W., Jones J.E. Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. Int. J. Biochem. 1989, 21:243-252.
20. Newton-Cheh C., Johnson T., Gateva V., Tobin M.D., Bochud M., Coin L., Najjar S.S., Zhao J.H., Heath S.C., Eyheramendy S., Papadakis K., Voight B.F., Scott L.J., Zhang F., Farrall M., Tanaka T., Wallace C., Chambers J.C., Khaw K.T., Nilsson P., van der Harst P., Polidoro S., Grobbee D.E., Onland-Moret N.C., Bots M.L., Wain L.V., Elliott K.S., Teumer A., Luan J., Lucas G., Kuusisto J., Burton P.R., Hadley D., McArdle W.L., Wellcome Trust Case Control C., Brown M., Dominiczak A., Newhouse S.J., Samani N.J., Webster J., Zeggini E., Beckmann J.S., Bergmann S., Lim N., Song K., Vollenweider P., Waeber G., Waterworth D.M., Yuan X., Groop L., Orho-Melander M., Allione A., Di Gregorio A., Guarrera S., Panico S., Ricceri F., Romanazzi V., Sacerdote C., Vineis P., Barroso I., Sandhu M.S., Luben R.N., Crawford G.J., Jousilahti P., Perola M., Boehnke M., Bonnycastle L.L., Collins F.S., Jackson A.U., Mohlke K.L., Stringham H.M., Valle T.T., Willer C.J., Bergman R.N., Morken M.A., Doring A., Gieger C., Illig T., Meitinger T., Org E., Pfeufer A., Wichmann H.E., Kathiresan S., Marrugat J., O'Donnell C.J., Schwartz S.M., Siscovick D.S., Subirana I., Freimer N.B., Hartikainen A.L., McCarthy M.I., O'Reilly P.F., Peltonen L., Pouta A., de Jong P.E., Snieder H., van Gilst W.H., Clarke R., Goel A., Hamsten A., Peden J.F., Seedorf U., Syvanen A.C., Tognoni G., Lakatta E.G., Sanna S., Scheet P., Schlessinger D., Scuteri A., Dorr M., Ernst F., Felix S.B., Homuth G., Lorbeer R., Reffelmann T., Rettig R., Volker U., Galan P., Gut I.G., Hercberg S., Lathrop G.M., Zelenika D., Deloukas P., Soranzo N., Williams F.M., Zhai G., Salomaa V., Laakso M., Elosua R., Forouhi N.G., Volzke H., Uiterwaal C.S., van der Schouw Y.T., Numans M.E., Matullo G., Navis G., Berglund G., Bingham S.A., Kooner J.S., Connell J.M., Bandinelli S., Ferrucci L., Watkins H., Spector T.D., Tuomilehto J., Altshuler D., Strachan D.P., Laan M., Meneton P., Wareham N.J., Uda M., Jarvelin M.R., Mooser V., Melander O., Loos R.J., Elliott P., Abecasis G.R., Caulfield M., Munroe P.B. Genome-wide association study identifies eight loci associated with blood pressure. Nat. Genet. 2009, 41:666-676.
21. Pereg D., Dewailly E., Poirier G.G., Ayotte P. Environmental exposure to polychlorinated biphenyls and placental CYP1A1 activity in Inuit women from northern Quebec. Environ. Health Perspect. 2002, 110:607-612.
22. Poland A., Glover E., Kende A.S. Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem. 1976, 251:4936-4946.
23. Poland A., Teitelbaum P., Glover E., Kende A. Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor. Mol. Pharmacol. 1989, 36:121-127.
24. Ritter R., Scheringer M., MacLeod M., Moeckel C., Jones K.C., Hungerbuhler K. Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the United Kingdom. Environ. Health Perspect. 2011, 119:225-231.
25. Roy N.K., Walker N., Chambers R.C., Wirgin I. Characterization and expression of cytochrome P4501A in Atlantic sturgeon and shortnose sturgeon experimentally exposed to coplanar PCB 126 and TCDD. Aquat. Toxicol. 2011, 104:23-31.
26. Rudge C.V., Sandanger T., Rollin H.B., Calderon I.M., Volpato G., Silva J.L., Duarte G., Neto C.M., Sass N., Nakamura M.U., Odland J.O., Rudge M.V. Levels of selected persistent organic pollutants in blood from delivering women in seven selected areas of Sao Paulo State, Brazil. Environ. Int. 2012, 40:162-169.
27. Rylander L., Nilsson-Ehle P., Hagmar L. A simplified precise method for adjusting serum levels of persistent organohalogen pollutants to total serum lipids. Chemosphere 2006, 62:333-336.
28. Safe S., Bandiera S., Sawyer T., Robertson L., Safe L., Parkinson A., Thomas P.E., Ryan D.E., Reik L.M., Levin W., et al. PCBs: structure-function relationships and mechanism of action. Environ. Health Perspect. 1985, 60:47-56.
29. Salihovic S., Mattioli L., Lindstrom G., Lind L., Lind P.M., van Bavel B. A rapid method for screening of the Stockholm Convention POPs in small amounts of human plasma using SPE and HRGC/HRMS. Chemosphere 2012, 86:747-753.
30. Sandau C.D., Sjodin A., Davis M.D., Barr J.R., Maggio V.L., Waterman A.L., Preston K.E., Preau J.L., Barr D.B., Needham L.L., Patterson D.G. Comprehensive solid-phase extraction method for persistent organic pollutants. Validation and application to the analysis of persistent chlorinated pesticides. Anal. Chem. 2003, 75:71-77.
31. Sauna Z.E., Kimchi-Sarfaty C. Understanding the contribution of synonymous mutations to human disease. Nat. Rev. Genet. 2011, 12:683-691.
32. Schade G., Heinzow B. Organochlorine pesticides and polychlorinated biphenyls in human milk of mothers living in northern Germany: current extent of contamination, time trend from 1986 to 1997 and factors that influence the levels of contamination. Sci. Total Environ. 1998, 215:31-39.
33. Schweikl H., Taylor J.A., Kitareewan S., Linko P., Nagorney D., Goldstein J.A. Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 1993, 3:239-249.
34. Shimada T., Inoue K., Suzuki Y., Kawai T., Azuma E., Nakajima T., Shindo M., Kurose K., Sugie A., Yamagishi Y., Fujii-Kuriyama Y., Hashimoto M. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice. Carcinogenesis 2002, 23:1199-1207.
35. Shimada T., Yun C.H., Yamazaki H., Gautier J.C., Beaune P.H., Guengerich F.P. Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Mol. Pharmacol. 1992, 41:856-864.
36. Tang Y.M., Wo Y.Y., Stewart J., Hawkins A.L., Griffin C.A., Sutter T.R., Greenlee W.F. Isolation and characterization of the human cytochrome P450 CYP1B1 gene. J. Biol. Chem. 1996, 271:28324-28330.
37. van den Berg M., Sinnige T.L., Tysklind M., Bosveld A.T., Huisman M., Koopmans-Essenboom C., Koppe J.G. Individual PCBs as predictors for concentrations of non and mono-ortho PCBs in human milk. Environ. Sci. Pollut. Res. Int. 1995, 2:73-82.
38. van Duursen M.B., Sanderson J.T., van den Berg M. Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: polymorphisms and interindividual variation in expression and inducibility. Toxicol. Sci. 2005, 85:703-712.
39. Yamazaki K., Suzuki M., Itoh T., Yamamoto K., Kanemitsu M., Matsumura C., Nakano T., Sakaki T., Fukami Y., Imaishi H., Inui H. Structural basis of species differences between human and experimental animal CYP1A1s in metabolism of 3,3',4,4',5-pentachlorobiphenyl. J. Biochem. 2011, 149:487-494.